| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sampsell David H. | VP, CORP. DEV, GC & CORP. SEC. | 9350 EXCELSIOR BLVD, SUITE 700, HOPKINS | /s/ Joshua L. Colburn, Attorney-in-Fact | 25 Nov 2025 | 0001540299 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DGII | Common Stock | Award | $0 | +7.13K | +0.02% | $0.00 | 31.8M | 21 Nov 2025 | Direct | F1 |
| transaction | DGII | Common Stock | Tax liability | -$32.5K | -813 | 0% | $40.02 | 31.7M | 22 Nov 2025 | Direct | |
| transaction | DGII | Common Stock | Options Exercise | $79.2K | +4.73K | +0.01% | $16.75 | 31.8M | 24 Nov 2025 | Direct | |
| transaction | DGII | Common Stock | Sale | -$189K | -4.73K | -0.01% | $40.00 | 31.7M | 24 Nov 2025 | Direct | |
| transaction | DGII | Common Stock | Options Exercise | $188K | +8.75K | +0.03% | $21.53 | 31.8M | 25 Nov 2025 | Direct | |
| transaction | DGII | Common Stock | Sale | -$363K | -8.75K | -0.03% | $41.52 | 31.8M | 25 Nov 2025 | Direct | F2 |
| holding | DGII | Common Stock | 64.9K | 21 Nov 2025 | By Revocable Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DGII | Employee Stock Option (right to buy) | Options Exercise | $0 | -4.73K | -100% | $0.00 | 0 | 24 Nov 2025 | Common Stock | 4.73K | $16.75 | Direct | F3 |
| transaction | DGII | Employee Stock Option (right to buy) | Options Exercise | $0 | -8.75K | -96.43% | $0.00 | 324 | 25 Nov 2025 | Common Stock | 8.75K | $21.53 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Restricted stock units scheduled to vest in four substantially equal increments on each of November 21, 2026, 2027, 2028 and 2029. |
| F2 | Reflects the weighted average price of 8,748 shares of common stock of the issuer sold by the reporting person in multiple transactions on November 25, 2025 with sale prices ranging from $41.40 to $41.69 per share. The reporting person undertakes to provide upon request by U.S. Securities and Exchange Commission staff, the issuer, or a securityholder of the issuer full information regarding the number of shares sold at each separate price. |
| F3 | Fully vested. |
| F4 | The option vests as to 25% of the shares on November 30, 2022 and thereafter in 36 monthly installments. |